1. Home
  2. ARI vs RCUS Comparison

ARI vs RCUS Comparison

Compare ARI & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$9.96

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.36

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARI
RCUS
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
2.8B
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
ARI
RCUS
Price
$9.96
$22.36
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$10.83
$28.89
AVG Volume (30 Days)
929.1K
1.4M
Earning Date
02-09-2026
02-24-2026
Dividend Yield
10.08%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
$269,296,000.00
$240,000,000.00
Revenue This Year
$23.46
N/A
Revenue Next Year
$16.03
N/A
P/E Ratio
$11.18
N/A
Revenue Growth
67.16
N/A
52 Week Low
$7.70
$6.50
52 Week High
$11.11
$26.40

Technical Indicators

Market Signals
Indicator
ARI
RCUS
Relative Strength Index (RSI) 46.84 48.93
Support Level $9.94 $20.70
Resistance Level $10.18 $23.78
Average True Range (ATR) 0.19 1.41
MACD 0.01 0.01
Stochastic Oscillator 49.53 43.25

Price Performance

Historical Comparison
ARI
RCUS

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: